Interdisciplinary recognizing and managing of drug-induced tardive oromandibular dystonia: two case reports-Reference-Cited by-同舟云学术

Interdisciplinary recognizing and managing of drug-induced tardive oromandibular dystonia: two case reports

Published:2018-09-26 Issue:11 Volume:6 Page:2150-2155
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Bakke Merete¹^ORCID,Henriksen Tove²,Biernat Heidi Bryde²,Dalager Torben²,Møller Eigild²

Affiliation:

1. Department of Odontology; Faculty of Medical and Health Sciences; University of Copenhagen; Copenhagen Denmark

2. Department of Neurology and Clinical Neurophysiology (Dystonia Clinic); Bispebjerg University Hospital; University of Copenhagen; Copenhagen Denmark

Publisher

Wiley

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccr3.1548/fullpdf

Reference15 articles.

1. Tardive and idiopathic oromandibular dystonia: a clinical comparison;Tan;J. Neurol. Neurosurg. Psychiatry,2000

2. Drug-induced tardive syndromes;Ortí-Pareja;Parkinsonism Relat. Disord.,1999

3. Oromandibular dystonia - functional and clinical characteristics: a report on 21 cases;Bakke;Oral Surg. Oral Med. Oral Pathol. Oral Radiol.,2012

4. Waln , O. J. Jankovic 2013 An Update on Tardive Dyskinesia: From phenomenology to treatment

5. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study;Woods;J. Clin. Psychiatry,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medications Affecting Outcomes and Prognosis of Dental Treatment;Dental Clinics of North America;2024-10

2. Task-Specific Drinking Tremor;Journal of Movement Disorders;2023-01-31

3. Impact-Tardive Dyskinesia (Impact-TD) Scale;The Journal of Clinical Psychiatry;2022-11-28

4. Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System;Toxins;2022-04-14

5. Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations;Neuropsychiatric Disease and Treatment;2021-05